Co-Diagnostics Inc (NASDAQ:CODX) gapped up prior to trading on Thursday . The stock had previously closed at $2.96, but opened at $3.01. Co-Diagnostics shares last traded at $2.78, with a volume of 59,714 shares trading hands.
A number of brokerages have recently weighed in on CODX. Zacks Investment Research cut shares of Co-Diagnostics from a “buy” rating to a “hold” rating in a research note on Tuesday, February 11th. HC Wainwright restated a “buy” rating and issued a $2.00 price objective on shares of Co-Diagnostics in a research note on Friday, January 3rd.
The stock’s 50 day moving average price is $2.11 and its two-hundred day moving average price is $1.31.
Co-Diagnostics Company Profile (NASDAQ:CODX)
Co-Diagnostics, Inc, a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc was founded in 2013 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Co-Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Co-Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.